Investment
Features
FeesSafety
Academy
More
Pluang+

Avantor to report Q3 2026 earnings on Oct 28 with a live webcast conference call.

Company Fundamentals
01 Oct 2026
PRNewsWire
View Source
Neutral
Avantor to report Q3 2026 earnings on Oct 28 with a live webcast conference call.

Avantor, a global provider of products and services for life sciences and advanced technology, will announce its third quarter 2026 financial results on October 28 before the market opens. The company will hold a conference call at 8:00 a.m. Eastern Time the same day, accessible via a live webcast on its investor website. This event is important for investors to assess Avantor's financial health and outlook in the life sciences sector. A replay of the webcast will be available for 30 days after the call.

Avantor's upcoming Q3 2026 earnings report offers context for readers following the company. For readers following health-sector stocks, here is Pluang's market snapshot as of Oct 01, 2026 15:41 WIB: out of 100 priced US health-sector stocks, 37 rose and 54 fell. Notable movers include ClearPoint Neuro Inc (CLPT) at USD 12.01 with a 1-day change of -1.64% and a typical hold time on Pluang of 9 days, Ginkgo Bioworks Holdings Inc (DNA) at USD 13.04 with a 1-day change of +1.64% and Pluang order activity showing 83% Buy, and Summit Therapeutics Inc (SMMT) at USD 17.18 with a 1-day change of +1.60% but 100% Sell order activity on Pluang.

More News

Microsoft stock grew 14-fold since 2014 under Nadella, but heavy AI spending raises questions on future growth.

Microsoft stock grew 14-fold since 2014 under Nadella, but heavy AI spending raises questions on future growth.

Since Satya Nadella became CEO in 2014, Microsoft stock has increased roughly 14 times, delivering an annual growth rate of 23%. This remarkable turnaround ended 14 years of negative growth for the company. However, with Microsoft now investing heavi...

Market News
Neutral
2 hours ago
Reckitt Benckiser faces mixed Q3 sales forecasts but retains buy ratings from UBS and Jefferies.

Reckitt Benckiser faces mixed Q3 sales forecasts but retains buy ratings from UBS and Jefferies.

Reckitt Benckiser's third-quarter sales forecasts vary between UBS and Jefferies, though both maintain 'buy' ratings. UBS predicts 3.7% like-for-like sales growth, expecting broad-based improvements and strong emerging market momentum, while Jefferie...

Market News
Neutral
4 hours ago
Lakewood-Amedex CEO to present new antimicrobial data at three major biotech conferences in October

Lakewood-Amedex CEO to present new antimicrobial data at three major biotech conferences in October

Lakewood-Amedex Biotherapeutics announced that CEO Kelvin Cooper, Ph.D., will participate in three key industry events in October 2026, including the Maxim Growth Summit, ThinkEquity Conference, and IDWeek. At these events, Dr. Cooper will present da...

Market News
Neutral
4 hours ago
Kyndryl opens AI Innovation Lab in Dallas, creating 300 jobs and boosting US AI adoption.

Kyndryl opens AI Innovation Lab in Dallas, creating 300 jobs and boosting US AI adoption.

Kyndryl has launched its first U.S. AI Innovation Lab in the Dallas-Fort Worth area, aiming to create up to 300 skilled jobs in AI and technology over four years. The lab will help customers modernize technology for AI adoption using Kyndryl's Agenti...

Market News
Bullish
4 hours ago
Equinix schedules Q3 2026 earnings call for October 28 to discuss financial results.

Equinix schedules Q3 2026 earnings call for October 28 to discuss financial results.

Equinix, a global digital infrastructure company, announced its quarterly earnings call for Q3 2026 will be held on October 28, 2026, at 5:30 p.m. ET. The company will review its financial results for the period ending September 30, 2026. Investors c...

Company Fundamentals
Neutral
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App